Abstract
The outbreak of Ebola virus disease in West Africa is the largest ever recorded. Numerous treatment alternatives for Ebola have been considered, including widely available repurposed drugs, but initiation of enrollment into clinical trials has been limited. The proposed trial is an adaptive platform design. Multiple agents and combinations will be investigated simultaneously. Additionally, new agents may enter the trial as they become available, and failing agents may be removed. In order to accommodate the many possible agents and combinations, a critical feature of this design is the use of response adaptive randomization to assign treatment regimens. As the trial progresses, the randomization ratio evolves to favor the arms that are performing better, making the design also suitable for all-cause pandemic preparedness planning. The study was approved by US and Sierra Leone ethics committees, and reviewed by the US Food and Drug Administration. Additionally, data management, drug supply lines, and local sites were prepared. However, in response to the declining epidemic seen in February 2015, the trial was not initiated. Sierra Leone remains ready to rapidly activate the protocol as an emergency response trial in the event of...Continue Reading
References
Oct 17, 2012·Proceedings of the National Academy of Sciences of the United States of America·Gene Garrard OlingerLarry Zeitlin
Aug 24, 2013·Science Translational Medicine·James PettittGene G Olinger
Oct 3, 2013·Antiviral Research·Yousuke FurutaDale L Barnard
Jan 28, 2014·Antiviral Research·Sophie J SmitherMark S Lever
Mar 4, 2014·Antiviral Research·Lisa OestereichStephan Günther
May 3, 2014·PLoS Neglected Tropical Diseases·Lisa OestereichStephan Günther
Jul 30, 2014·Lancet·Mahesh K B ParmarMatthew R Sydes
Aug 22, 2014·Science Translational Medicine·Emily P ThiThomas W Geisbert
Aug 28, 2014·The Journal of Infectious Diseases·David S Fedson
Sep 23, 2014·The New England Journal of Medicine·UNKNOWN WHO Ebola Response TeamZabulon Yoti
Dec 2, 2014·The Lancet Infectious Diseases·France MentréDenis Malvy
Apr 16, 2015·PLoS Medicine·Ben S CooperJohn Whitehead
Apr 18, 2015·Science·Elena Bekerman, Shirit Einav
Apr 24, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Colleen S KraftUNKNOWN Nebraska Biocontainment Unit and the Emory Serious Communicable Diseases Unit
May 12, 2015·Annals of Internal Medicine·Allison M LiddellTimothy M Uyeki
May 21, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Diana F FlorescuPhilip W Smith
Jun 4, 2015·Emerging Microbes & Infections·Shan Lu
Jun 4, 2015·Emerging Microbes & Infections·Jennifer KouznetsovaAdolfo García-Sastre
Jun 5, 2015·The Lancet. Respiratory Medicine·Marta Mora-RilloUNKNOWN La Paz-Carlos III University Hospital Isolation Unit
Jun 9, 2015·Clinical Chemistry and Laboratory Medicine : CCLM·Belen Fernandez-PunteroAntonio Buno
Jun 20, 2015·Genome Announcements·Concetta CastillettiMaria R Capobianchi
Jun 25, 2015·MBio·David S FedsonSteven M Opal
Jul 6, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·David S Fedson, Ole Martin Rordam
Aug 12, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan van GriensvenLutgarde Lynen
Citations
May 20, 2016·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Dietrich Haubenberger, David B Clifford
Oct 21, 2016·Clinical Pharmacology and Therapeutics·M R TrusheimL J Esserman
Apr 25, 2017·Expert Review of Clinical Pharmacology·François Curtin, Stephane Heritier
Nov 28, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Susan S EllenbergKeith P W J McAdam
Jul 2, 2016·Clinical Trials : Journal of the Society for Clinical Trials·Erica H Brittain, Michael A Proschan
Sep 12, 2018·PloS One·Matthias BruecknerPeter Horby
Mar 8, 2019·Statistical Methods in Medical Research·Tong-Yu LuSiu Hung Cheung
Apr 25, 2019·Journal of Biopharmaceutical Statistics·Yunyun JiangValerie Durkalski-Mauldin
Aug 28, 2019·Clinical Trials : Journal of the Society for Clinical Trials·Rebecca S Slack TidwellJ Jack Lee
Jan 1, 2020·PLoS Medicine·Elvin H GengMaya L Petersen
Oct 22, 2019·Clinical Trials : Journal of the Society for Clinical Trials·Kert VieleBenjamin R Saville
Sep 8, 2017·Neurology·Brandy E FuremanJacqueline A French
Mar 22, 2020·Pharmaceutical Statistics·Kert VieleKristine Broglio
Apr 17, 2020·The American Journal of Tropical Medicine and Hygiene·Catherine E Oldenburg, Thuy Doan
Sep 20, 2019·Trials·Jay J H ParkEdward J Mills
Jan 5, 2018·Statistical Methods in Medical Research·Wenfu XuSiu Hung Cheung
Apr 12, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Amanda M Rojek, Peter W Horby
Jul 14, 2018·Frontiers in Immunology·Victor B TalisaDerek C Angus
May 20, 2020·Trials·Leanne McCabeUNKNOWN SEARCH investigators
Dec 20, 2019·Trials·Rieke van der Graaf, Phaik Yeong Cheah
Apr 20, 2018·Statistics in Medicine·Pei-Fang Su, Siu Hung Cheung
Oct 14, 2020·Journal of Medical Ethics·Maud O JansenTanya L Zakrison
Aug 18, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brian M AlexanderUNKNOWN GBM AGILE Network
Jul 25, 2019·Contemporary Clinical Trials Communications·Ellie G SidenEdward J Mills
Mar 12, 2021·Trials·Kim May LeeJames Wason
Jul 6, 2020·Clinical Therapeutics·Elias Laurin MeyerFranz König
Apr 19, 2021·The Lancet Global Health·Jay J H ParkEdward J Mills
Jul 10, 2021·Annals of the American Thoracic Society·Charles S Dela CruzRichard G Wunderink
Jul 21, 2020·ACS Infectious Diseases·Sirle Saul, Shirit Einav
Aug 18, 2021·BMC Medical Research Methodology·Vance W BergerUNKNOWN Randomization Innovative Design Scientific Working Group
Nov 19, 2021·Contemporary Clinical Trials·Alyssa M VanderbeekChristina Yap